Lipophilicity Modification

Lipophilicity Modification is a solubility enhancement strategy that alters the lipid solubility of a bioactive compound through structural or chemical changes to improve its membrane permeability and overall bioavailability.

238

Publications

10.2K

Citations

1.4K

Authors

400

Institutions

Publications per year

2017–2026

75

Authors

1.4K

  1. JS
    James S. Scott

    AstraZeneca (United Kingdom), United Kingdom

    5 publications · 283 citations

    5

    h-index

  2. BL
    Bruno Linclau

    University of Southampton, United Kingdom

    4 publications · 242 citations

    4

    h-index

  3. RK
    Ravindra K. Pandey

    Roswell Park Comprehensive Cancer Center, United States

    4 publications · 141 citations

    4

    h-index

  4. EC
    Elisabetta Chiarparin

    AstraZeneca (United Kingdom), United Kingdom

    3 publications · 210 citations

    3

    h-index

  5. AR
    Allan R. Oseroff

    Roswell Park Comprehensive Cancer Center, United States

    3 publications · 119 citations

    3

    h-index

1–5 of 1.4K

Venues

  1. Journal of Medicinal Chemistry

    34 publications · 2K citations

    27

    h-index

  2. Bioorganic & Medicinal Chemistry Letters

    7 publications · 193 citations

    7

    h-index

  3. Journal of Agricultural and Food Chemistry

    6 publications · 520 citations

    6

    h-index

  4. International Journal of Pharmaceutics

    6 publications · 270 citations

    6

    h-index

  5. The Journal of Organic Chemistry

    JOC · 6 publications · 177 citations

    6

    h-index

1–5